Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1181 |
Bradykinin (2-9)
Des-Arg1-bradykinin |
Bradykinin Receptor | GPCR/G Protein |
Bradykinin (2-9) (Des-Arg1-bradykinin),是Bradykinin的一种氨基端截短肽类代谢物,通过Aminopeptidase P的切割作用形成。 | |||
TP1277 |
Bradykinin
缓激肽 |
Endogenous Metabolite; Bradykinin Receptor | GPCR/G Protein; Metabolism |
Bradykinin 是由激肽释放酶-激肽系统产生的活性肽。 它是炎症调节因子和神经调节因子,对几种血管和肾功能也有调节作用。 | |||
TP1445 |
[Des-Arg9]-Bradykinin acetate
[Des-Arg9]-缓激肽醋酸盐 |
Bradykinin Receptor | GPCR/G Protein |
[Des-Arg9]-Bradykinin acetate 是一种选择性缓激肽 B1 受体激动剂。 | |||
T5048 |
SSR240612
|
Bradykinin Receptor | GPCR/G Protein |
SSR240612 是口服有活性的非肽类缓激肽 B1 (bradykinin B1) 受体特异性拮抗剂。 | |||
T22344 |
Icatibant Acetate
|
Bradykinin Receptor | GPCR/G Protein |
Icatibant acetate 是一种特异性缓激肽 B2 受体拮抗剂,其 IC50=1.07 nM,Ki=0.798 nM。 | |||
T2086 |
ELN-441958
ELN 441958 |
Bradykinin Receptor | GPCR/G Protein |
ELN-441958是一种B1受体拮抗剂,能够抑制B1激动剂配体[3H] DAKD 与IMR-90细胞结合(Ki:0.26 nM),相较于B2受体,它对B1受体的抑制作用具有更高的选择性,且比抑制μ阿片受体选择性高500多倍,比抑制δ阿片受体选择性高2000多倍。 | |||
T7645 |
[Des-Arg9]-Bradykinin
[Des-Arg9]-Bradykinin(2TFA),[Des-Arg9]-缓激肽 |
Bradykinin Receptor | GPCR/G Protein |
[Des-Arg9]-Bradykinin ([Des-Arg9]-Bradykinin(2TFA)) 是 Bradykinin(B1) 受体激动剂,对 B1受体选择性大于B2受体。 | |||
T8809 |
[Des-Arg9]-Bradykinin TFA
|
Bradykinin Receptor | GPCR/G Protein |
[Des-Arg9]-Bradykinin TFA 是一种缓激肽 (B1) 受体激动剂,对 B1 的选择性优于对 B2 受体的选择性。 | |||
T36442L |
(Hyp³)-Bradykinin acetate
(Hyp³)-Bradykinin acetate (37642-65-2 Free base) |
Bradykinin Receptor | GPCR/G Protein |
(Hyp³)-Bradykinin acetate 是一种缓激肽 B2 受体激动剂,可刺激培养的人成纤维细胞中磷酸肌醇的产生。 | |||
TP2268L |
Lys-Bradykinin acetate(342-10-9 free base)
|
Bradykinin Receptor | GPCR/G Protein |
Lys-Bradykinin acetate(342-10-9 free base) 是一种内源性缓激肽受体激动剂。 | |||
TP2075L |
Bombinakinin M acetate
Bombinakinin M acetate(509151-65-9 free base) |
Bradykinin Receptor | GPCR/G Protein |
Bombinakinin M acetate 是一种有效的缓激肽受体激动剂,对哺乳动物动脉平滑肌缓激肽受体具有高度选择性,其效力比缓激肽高约 50 倍。 | |||
T33421 |
MK-0686
MK0686 |
Bradykinin Receptor | GPCR/G Protein |
MK-0686 是一种可口服的缓激肽 B1 受体拮抗剂,具有潜在的抗炎活性。 | |||
TP1918L |
Lys-[Des-Arg9]Bradykinin,TFA
Lys-[Des-Arg9]Bradykinin,TFA 71800-36-7(fb-tfa) |
Bradykinin Receptor | GPCR/G Protein |
Lys-[Des-Arg9]Bradykinin,TFA (71800-36-7 free base) 是内源性强效和高选择性的缓激肽 B1 受体激动剂(对人 B1 和 B2 受体的 Ki 值分别为 0.12 和 > 30000 nM)。降低体内外周血管阻力的降压药。比 [Des-Arg9]-缓激肽强 16 倍。 | |||
TP1918L1 |
Lys-[Des-Arg9]Bradykinin acetate
Lys-[Des-Arg9]Bradykinin acetate (71800-36-7 free base) |
Bradykinin Receptor | GPCR/G Protein |
Lys-[Des-Arg9]Bradykinin acetate (71800-36-7 free base) 是一种内源性强效和高选择性的缓激肽 B1 受体激动剂(对人 B1 和 B2 受体的 Ki 值分别为 0.12 和 > 30000 nM)。降低体内外周血管阻力的降压药。比 [Des-Arg9]-缓激肽强 16 倍。 | |||
T34485 |
Safotibant
LF220542,LF 220542,LF 22-0542,LF-220542,LF-22-0542,LF22-0542 |
Bradykinin Receptor | GPCR/G Protein |
Safotibant (LF-22-0542) 是一种缓激肽 B1 受体拮抗剂,具有抗炎和镇痛活性,可用于局部治疗糖尿病性黄斑水肿。 | |||
TP1917L1 |
Sar-[D-Phe8]-des-Arg9-Bradykinin acetate
Sar-[D-Phe8]-des-Arg9-Bradykinin acetate(126959-88-4 free base) |
Bradykinin Receptor | GPCR/G Protein |
Sar-[D-Phe8]-des-Arg9-Bradykinin acetate(126959-88-4 free base) 是一种有效的选择性缓激肽 B1 受体激动剂(兔主动脉中的 EC50 = 9.02 nM),对氨肽酶、激肽酶 I 和 II (ACE) 以及中性内肽酶切割具有抗性。在体内表现出降血压和血管生成活性。 | |||
T26627L |
Anatibant 2HCl
Anatibant 2HCl(209733-45-9 Free base) |
Bradykinin Receptor | GPCR/G Protein |
Anatibant 2HCl 是一种小分子缓激肽B2受体拮抗剂,可用于治疗神经系统疾病,可能用于研究脑损伤。 | |||
TP1933 |
R715 TFA(185052-09-9 free base)
R 715 |
Bradykinin Receptor | GPCR/G Protein |
R715 TFA(185052-09-9 free base) 是强效和选择性缓激肽 B1 受体拮抗剂 (pA2 = 8.49)。它对B2 受体无活性。它减少神经性疼痛小鼠模型中的机械性过度伤害感受。它代谢稳定。 | |||
TP1931L1 |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate(96736-12-8 free base) |
cholecystokinin | GPCR/G Protein |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate ([D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate (96736-12-8 free base)) 是广谱神经肽反向激动剂和拮抗剂。 ghrelin 受体的强效完全反向激动剂(EC50 = 5.2 nM);减少组成型生长素释放肽受体信号传导。它也是速激肽、缓激肽、CCK 和铃蟾肽受体的拮抗剂。在体外诱导细胞凋亡并抑制癌细胞生长。 | |||
T4200 |
Sacubitril hemicalcium salt
AHU-377 (hemicalcium salt),LCZ696中间体,AHU377 calcium salt |
Neprilysin | Metabolism |
Sacubitril hemicalcium salt (AHU377 calcium salt) 是一种有效的 NEP 抑制剂,IC50=5 nM。它是研究心力衰竭药物 LCZ696 的组分之一。 | |||
T15347 | FR167344 free base | Others | Others |
FR167344 free base is an orally active and nonpeptide antagonist of bradykinin receptor B2. FR167344 free base displays a high-affinity binding to the B2 receptor (IC50: 65 nM). It has no binding affinity for the B1 receptor. | |||
T25555 |
JMV-1645
JMV1645,JMV 1645 |
||
JMV-1645 is an effective and selective B(1) bradykinin receptor antagonist. | |||
T24065 |
FK-3657
FK 3657,FK3657,FR-173657,FR 173657,FR173657 |
||
FK-3657 is a non-peptide antagonist of bradykinin (BK)-B2 receptor. | |||
T27377 |
FR190997
FR-190997,FR 190997 |
||
FR190997 is an agonist of bradykinin B2 receptor. | |||
T21060 |
NPC 567
|
||
NPC 567 is an antagonist of the bradykinin receptor. | |||
T69673 |
Deucrictibant
|
||
Deucrictibant is a bradykinin receptor antagonist. | |||
T63241 |
Fulimetibant
|
||
Fulimetibant 是缓激肽受体 (bradykinin receptor) 拮抗剂。 | |||
T70576 | NPC 17731 | ||
NPC 17731 is a bradykinin receptor antagonist. | |||
T70574 | NPC 17761 | ||
NPC 17761 is a bradykinin receptor antagonist. | |||
T25895 |
NVP-SAA164
SAA 164,SAA164,SAA-164,NVP SAA164 |
||
NVP-SAA164 is a nonpeptide bradykinin B1 receptor antagonist agent. | |||
T70750 |
Deltibant
|
||
Deltibantis a bradykinin receptor antagonist. | |||
TP2268 |
Lys-Bradykinin
|
Others | Others |
Endogenous bradykinin receptor agonist | |||
T76385 |
[Tyr8] Bradykinin
|
||
[Tyr8] Bradykinin 是B2激肽受体 (B2kinin receptor) 的激动剂,能刺激ERK1/2磷酸化,并可作为内标。 | |||
T80117 |
Lys-(Des-Arg9,Leu8)-Bradykinin
|
Bradykinin Receptor | GPCR/G Protein |
Lys-(Des-Arg9,Leu8)-Bradykinin为缓激肽B1受体的拮抗剂。 | |||
T80072 |
Des-Arg9-[Leu8]-Bradykinin acetate
|
Bradykinin Receptor | GPCR/G Protein |
Des-Arg9-[Leu8]-Bradykinin acetate 是一种B1R(缓激肽受体1)拮抗剂,主要应用于肾纤维化的研究。 | |||
TP2076 |
[Phe8Ψ(CH-NH)-Arg9]-Bradykinin
|
||
Selective bradykinin B2 receptor agonist that is resistant to carboxypeptidase cleavage. 5-fold more potent and exhibits a more prolonged duration of action than bradykinin in vivo. | |||
T83500 |
[Des-Arg10]-HOE I40
|
||
[Des-Arg10]-HOE 140 是一种有效的 B1 缓激肽受体拮抗剂,具备生物活性。 | |||
T76212 |
B 9430
|
||
B 9430 是一种有效的缓激肽 B1/B2 受体拮抗剂。 | |||
T38544 |
Fasitibant chloride
MEN16132 free base,Fasitibant chloride |
||
Fasitibant chloride (MEN16132 free base) is a powerful and specific nonpeptide antagonist of the bradykinin B2 receptor (B2R). This compound effectively reduces joint pain and mitigates joint edema in a rat model of Carrageenan-induced arthritis. | |||
TP2075 |
Bombinakinin M
|
||
Potent bradykinin receptor agonist. Highly selective for mammalian arterial smooth muscle bradykinin receptors, displaying ~ 50-fold greater potency than bradykinin. Elicits dose-dependent contractile effects in smooth muscle of guinea pig ileum (EC50 = 4 | |||
T15547 |
Icatibant
艾替班特,HOE 140 |
Others | Others |
Icatibant is a selective and specific antagonist of the bradykinin B2 receptor (IC50 and Ki: 1.07 nM and 0.798 nM respectively). | |||
TP1931 |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P
|
||
Broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin receptor signaling. Also antagonist at tachykinin, bradykinin, CCK and bombesin receptors. In | |||
T27790 |
Labradimil
RMP-7,ALK-01-040,Receptor-mediated permeabiliser-7,DRG0182,DRG 0182,DRG-0182 |
||
Labradimil is a bradykinin B2 receptor agonist. Labradimil increases the permeability of human brain microvascular endothelial cell monolayers. Labradimil enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tu | |||
TP1918 |
Lys-[Des-Arg9]Bradykinin
|
||
Endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 receptors respectively). Hypotensive agent that reduces peripheral vascular resistance in vivo. 16-fold more potent than [Des-Arg9] | |||
T73646 |
Lys-[Des-Arg9]Bradykinin TFA
|
||
Lys-[Des-Arg9]Bradykinin TFA 是一种天然存在的激肽,是一种有效且高度选择性的缓激肽 B1受体激动剂,对人,小鼠和兔子的 B1受体的 Ki 值为 0.12 nM,1.7 nM 和 0.23 nM。Lys-[Des-Arg9]Bradykinin TFA 对 B2 受体的抑制活性较低。 | |||
T26627 |
Anatibant
LF16-0687,LF-16-0687,LF 160687,LF 16-0687,LF-160687 |
||
Anatibant 是一种有效的非肽缓激肽B2受体拮抗剂。Anatibant 降低实验性外伤性脑损伤后颅内高压和组织病理学损伤。 | |||
TP1917 |
Sar-[D-Phe8]-des-Arg9-Bradykinin
|
||
Potent and selective bradykinin B1 receptor agonist (EC50 = 9.02 nM in rabbit aorta) that is resistant to aminopeptidase, kininase I and II (ACE) and neutral endopeptidase cleavage. Exhibits hypotensive and angiogenic activity in vivo. | |||
TP1999 |
MEN 11270
|
||
Peptide antagonist of the B2 bradykinin receptor (pKi = 10.3); conformationally constrained cyclized analog of HOE 140. Blocks hypotension and bronchoconstriction in vivo. Displays selectivity for B2 over 29 other receptors and ion channels (pIC50 < 5.5). | |||
TP1662 |
Galanin Receptor Ligand M35
|
||
The chimeric peptide M35 [galanin (1-13)-bradykinin(2-9) amide] is a high-affinity galanin receptor ligand acting as a galanin receptor antagonist in the rat spinal cord, rat hippocampus and isolated mouse pancreatic islets. The radiolabelled M35 and perf | |||
TP2126 |
R 892
|
||
Potent and selective bradykinin B1 receptor antagonist (ID50 values are 2.8 and > 600 nM at B1 and B2 receptors respectively). Exhibits no intrinsic agonist activity and is resistant to aminopeptidase and kininase II (ACE) cleavage. Displays hypertensive |